CellaVision AB (publ) (CLVSF)
OTCMKTS · Delayed Price · Currency is USD
19.28
-0.63 (-3.16%)
At close: Jan 23, 2025
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of $419.82 million as of August 1, 2025. Its market cap has decreased by -30.77% in one year.
Market Cap
419.82M
Enterprise Value
406.91M
Revenue
79.02M
Ranking
n/a
PE Ratio
26.41
Stock Price
$19.28
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 54.35M to 419.82M, an increase of 672.42%. That is a compound annual growth rate of 11.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 419.82M | -10.62% |
| Dec 30, 2024 | 469.69M | -6.32% |
| Dec 29, 2023 | 501.37M | -4.32% |
| Dec 30, 2022 | 523.98M | -38.89% |
| Dec 30, 2021 | 857.50M | -4.04% |
| Dec 30, 2020 | 893.58M | 9.30% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |
| CytoDyn | 357.98M |